News >

Precision Medicine to Take Hold in Advanced Bladder Cancer

Caroline Seymour
Published: Monday, Aug 26, 2019

Parminder Singh, MD, a hematologist/oncologist at Mayo Clinic

Parminder Singh, MD

Beyond the availability of checkpoint inhibitors for patients with advanced bladder cancer, investigators are continuing to search for synergistic combinations, targeted therapies, and biomarkers of response that will further propel the field forward, explained Parminder Singh, MD.     
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut AllergySep 28, 20191.0
Enduring CME activity from the School of Breast Oncology®: 2018 Mid-Year Video UpdateSep 28, 20192.0
Publication Bottom Border
Border Publication
x